AChR Autoantibody Pathogenic Properties Are Heterogeneously Distributed and Undergo Temporal Changes Among Patients With Myasthenia Gravis
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200436. doi: 10.1212/NXI.0000000000200436. Epub 2025 Jul 18. ABSTRACT BACKGROUND AND OBJECTIVES: Acetylcholine receptor (AChR) autoantibodies contribute to myasthenia gravis (MG) pathogenesis …